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Agarwood หรือ กฤษณา (ไมห้อม) เป็นพืชจดัอยูใ่นจีนสั Aquilaria (วงศ ์ Thymelaeaceae) 
ในเอเชียพืชชนิดน้ีถูกน าไปผลิตเคร่ืองหอมและน ้ าหอม นอกจากนั้นยงัถูกน ามาใช้เป็นยาแผน
โบราณเพื่อสงบประสาท แกป้วดและยาช่วยในการยอ่ยอาหารในประเทศแถบเอเชียตะวนัออกและ
ประเทศจีน มีการน าใบอ่อนของพืชกฤษณา สปีชีส์ Aquilaria crassna ท่ีปลูกโดยเกษตรกรมาผลิต
เป็นชาเพื่อสุขภาพกันอย่างแพร่หลายในประเทศเวียดนาม กัมพูชาและไทย ผูผ้ลิตได้ท าการ
ประชาสัมพนัธ์เพื่อส่งเสริมการขายว่ามีฤทธ์ิทางเภสัชวิทยาหลายประการโดยปราศจากขอ้มูล
สนบัสนุนทางวิทยาศาสตร์ การศึกษาวิจยัน้ีมีวตัถุประสงค์เพื่อศึกษาฤทธ์ิทางเภสัชวิทยาของสาร
สกดัจากใบกฤษณา ไดแ้ก่ ฤทธ์ิและกลไกการออกฤทธ์ิในการตา้นเช้ือแบคทีเรีย  รวมทั้งฤทธ์ิในการ
ลดระดบัน ้าตาลในเลือด นอกจากนั้นยงัไดท้  าการตรวจสอบพฤกษเคมีเบ้ืองตน้และฤทธ์ิตา้นอนุมูล
อิสระตลอดจนทดสอบความเป็นพิษอยา่งเฉียบพลนัของสารสกดัดว้ย 
การตรวจสอบพฤกษเคมีเบ้ืองตน้พบวา่สารสกดัน ้าจากใบกฤษณา A. crassna ประกอบดว้ย  
แทนนิน ฟลาโวนอยด์ ซาโปนิน คาร์ดิแอกไกลโคไซด์ และสารประกอบฟีนอลิก การตรวจสอบ
ฤทธ์ิการตา้นอนุมูลอิสระซ่ึงท าโดยวิธี DPPH ABTS และ FRAP scavenging methods แสดงให้เห็น
ว่าสารสกดัมีฤทธ์ิในการตา้นอนุมูลอิสระค่อนขา้งแรงเม่ือเปรียบเทียบกบัสารมาตรฐาน ascorbic 
acid และ butylated hydroxytoluene การศึกษาฤทธ์ิตา้นแบคทีเรียโดยวิธี macro-dilution พบวา่สาร
สกดัสามารถยบัย ั้งการเจริญของเช้ือ Staphylococcus epidermidis โดยมีค่า MIC เท่ากบั   6 มิลลิกรัม
ต่อมิลลิลิตร ขณะท่ีค่า MBC เท่ากบั 12 มิลลิกรัมต่อมิลลิลิตร ผูว้ิจยัท าการสังเกตการเปล่ียนแปลง
ทางด้านสัณฐานวิทยาดว้ยจุลทรรศน์อิเล็กตรอนแบบส่องกราดและศึกษาฤทธ์ิต่อการสร้างไบโอ
ฟิล์มดว้ยการใช้กลอ้งจุลทรรศน์แบบเฟสคอนทราสท์ พบว่าสารสกดัไม่เพียงแต่มีผลท าให้เซลล์
บวมและบิดเบ้ียวเท่านั้นแต่สามารถยบัย ั้งการสร้างไบโอฟิล์มได้อีกด้วย และจากการใช้กล้อง
จุลทรรศน์อิเล็กตรอนแบบส่องผ่านพบวา่หลงัจากบ่มสารสกดันาน 24 ชัว่โมง ผนงัเซลล์แบคทีเรีย
เกิดการแตกเสียหายข้ึน ส าหรับการศึกษาฤทธ์ิลดระดบัน ้ าตาลในเลือดไดท้ าการศึกษาโดยใช้หนู
ขาวท่ีถูกชกัน าให้เกิดภาวะเบาหวานดว้ยสเตรปโตโซโตซิน จากการทดลองพบวา่ระดบัน ้ าตาลใน
เลือดไม่ลดลงหลังจากหนูได้รับสารสกัดเป็นเวลา 15 วนั ต่างจากกลุ่มของหนูท่ีได้รับยาตา้น
เบาหวานไกลเบนคลาไมด์  ผลการทดลองในคร้ังน้ีช้ีให้เห็นว่าสารสกัดน ้ าจากใบกฤษณา    
  
 
 
 
 
 
 
II 
A. crassna ไม่มีฤทธ์ิลดระดบัน ้ าตาลในเลือด การทดสอบพิษเฉียบพลนัในหนูถีบจกัร ไม่พบวา่หนู
ทดลองเกิดความเป็นพิษและไม่มีหนูทดลองตายในระหวา่งการทดสอบ หลงัจากไดรั้บสารสกดัใน
ขนาด 2,000 และ 15,000 มิลลิกรัมต่อกิโลกรัมของน ้าหนกัตวั  
จากการศึกษาในคร้ังน้ีสรุปไดว้า่ สารสกดัน ้ าจากใบกฤษณา A. crassna มีฤทธ์ิตา้นเช้ือ
แบคทีเรีย S. epidermidis โดยไม่พบวา่เกิดพิษเฉียบพลนัต่อหนูทดลอง สารสกดัมีกลไกการออก
ฤทธ์ิไปรบกวนการสร้างผนังเซลล์ของแบคทีเรียและยบัย ั้งการสร้างไบโอฟิล์ม อย่างไรก็ตาม  
ขอ้มูลท่ีได้จากการศึกษาน้ีบ่งช้ีให้เห็นว่าสารสกดัไม่มีฤทธ์ิตา้นเบาหวานท่ีถูกชักน าด้วยสเตรป     
โตโซโตซิน 
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ANTIBACTERIAL/CELL WALL/ACUTE TOXICITY/ANTIDIABETIC 
 
Agarwood or Krisana (Mai-Hom) is mainly produced by trees in the species 
of Aquilaria (family Thymelaeaceae). These plants are used for the production of 
incense and perfumes in Asia. It is also used as a traditional sedative, analgesic and 
digestive medicine throughout East Asia and China. The young leaves of cultivated 
Aquilaria crassna are widely used for production of Krisana health tea in Viet Nam, 
Cambodia and Thailand. It has been promoted by local manufacturers that agarwood 
tea possesses many pharmacological activities without any scientific evidences 
supporting the promotion. The main objectives of this study were to examine the 
antibacterial activity of the A. crassna leaf extract and its underlying mechanism. 
Anti-hyperglycemic action of the extract, as it is claimed, was also investigated. 
Moreover, phytochemical screening, antioxidant activity and acute toxicity were 
studied as well.   
Phytochemical evaluation of A. crassna showed the presence of tannins, 
flavonoids, saponins, cardiacglycoside and phenolic compounds in the aqueous 
extract of A. crassna leaves. Antioxidant activities were examined by DPPH, ABTS, 
and FRAP scavenging methods. The results indicated that the extract exhibited quite 
considerable antioxidant activity compared to the standards, ascorbic acid and 
  
 
 
 
 
 
 
IV 
butylated hydroxytoluene. By macro-dilution method, it was found that 
Staphylococcus epidermidis was susceptible to the extract with the MIC and MBC of 
6 and 12 mg/ml, respectively. Morphological changes of the microbe were observed 
by scanning electron microscopy, while the inhibitory effect on biofilm formation 
was evaluated by phase contrast microscopic analysis. The extract not only caused 
swelling and distortion of bacterial cells but also inhibited bacterial biofilm 
formation. Rupture of bacterial cell wall occurred after treated with the extract for   
24 h, observed by transmission electron microscopy. For anti-hyperglycemic 
examination, streptozotocin-induced diabetic rats were used. The results showed that 
after oral administration for 15 days, blood glucose level of the rats that received      
A. crassna leaves extract did not decrease compared to those of the groups that 
received glybenclamide, an antidiabetic drug. This result suggested that the aqueous 
extract of A. crassna leaves did not possess the hypoglycemic activity.  Acute toxicity 
in mice was conducted in accordance with the OECD for Testing of Chemicals 
(2001) guidelines. It showed no sign of toxicity or death of the rats at the doses of 
2,000 and 15,000 mg/kg body weight.  
In conclusion, the aqueous extract of A. crassna leaves possesses an in 
vitro antibacterial activity against S. epidermidis, with no sign of acute oral toxicity in 
mice, probably by interfering with bacterial cell wall synthesis and inhibiting biofilm 
formation. However, the data from this study suggests that the extract does not have 
anti-diabetic activity induced by streptozotocin. 
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CHAPTER I 
INTRODUCTION 
 
Plant and plant products have been used as sources of medicine since long.  
Traditional medicines and food from plants are more likely to yield 
pharmacologically active compounds. Bioactive compounds found in several 
medicinal plants have been shown to have health benefits, for example, antioxidant, 
antimutagenic, anticarcinogenic, antihypertensive, antidiabetic and antimicrobial 
activities (Cao and Cao, 1999; Geleijnse, Launer, Hofman, Pols and Witteman, 1999; 
Kahkonen et al., 1999; Yen, Duh and Tsai, 2002). Many medicinal properties of 
plants have been scientifically investigated and proved for low toxicity (Valiathan, 
1998). In addition to being relatively safe, accessibility and affordability are more 
advantages of herbal medicines. 
Agarwood or Krisana (Mai-Hom) is mainly produced by trees in the species 
of Aquilaria (family Thymelaeaceae). These plants provide an economically 
important natural product which is used for the production of incense, perfumes and 
traditional medicines in Asia (Feng, Yang and Wang, 2011). In Thailand, at least four 
species of agarwood trees are found in tropical rainforest areas of Thailand, 
namely Aquilaria crassna Pierre ex Lecomte, A. subintegra, A. malaccensis and A. 
rugosa (Eiadthong, 2007). The plants are not only one of the most valuable plants 
traded internationally but also have been used in Thai pharmaceutical products,    
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such as carminative and antispasmodic agents. It has been reported that agarwood is 
used as a traditional sedative, analgesic and digestive medicine throughout East Asia 
and China (Hu, Gao, Ling and Liu, 2009; Feng, Yang and Wang, 2011). Aquilaria 
species has been used as one of the active ingredients in the traditional Thai 
pharmaceutical preparation Krisanaglun as an antispasmodic, antidiarrheal and 
antiflatulence agent for more than fifty years. It has also been used as the ingredient 
of Ya-hom as a cardiovascular function enhancer in fainted patient (Miniyar, Chitre, 
Karve, Deuskar and Jain, 2008). Based on Thai folklore information, several parts of 
agarwood have been used for a long time in the treatment of infectious diseases such 
as diarrhoea, dysentery and skin diseases. However, scientific study with respect to its 
usefulness in the treatments of infectious diseases is very limited. Infectious diseases 
represent an important cause of morbidity and mortality among population, 
particularly in developing countries. Generally, species of the genus Staphylococcus 
are normal and abundant colonizer of the human skin and mucous membranes. 
Staphylococcus epidermidis is nowadays seen as an important opportunistic 
pathogen. S. epidermidis represents the most common source of infections on 
indwelling medical devices or contact lenses. It is now the most frequent cause of 
hospital-acquired infections (Raad, Alrahwan and Rolston, 1998 ). Treatment of the 
infection caused by this microorganism is complicated due to its specific antibiotic 
resistance genes and the formation of biofilms and multicellular agglomerations that 
have intrinsic resistance to antibiotics and mechanisms of host defense (Costerton, 
Stewart and Greenberg, 1999). The increasing failure of chemotherapeutic agents and 
antibiotic resistance exhibited by pathogenic microbial infectious agents has led to the 
  
 
 
 
 
 
 
3 
screening of several medicinal plants for their potential antimicrobial activity 
(Sharma, Patel, Rawat, Ramteke and Verma, 2010).                              
Owing to over-exploitation, many species of agarwood in the genus Aquilaria 
are nowadays considered as endangered species of Southeast Asia. Therefore, 
cultivation of agarwood is encouraged to reduce the harvest from wild populations. 
Since it takes about 10 years before the wood can produce valuable essential oil or 
resin, leaves from young agarwood are collected for production of healthy tea in Viet 
Nam, Cambodia and Thailand. However, it has been promoted by local manufacturers 
that agarwood tea possess many pharmacological activities, such as lipid lowering 
effect, anti-gout and antidiabetic effects without scientific evidence to support.  
Diabetes is a chronic metabolic disease characterized by hyperglycemic 
caused by dysfunction in carbohydrate, protein and fat metabolism due to the insulin 
produced by the body is insufficient, or cells do not respond properly to the insulin 
that is produced (Ramachandran, Naveen, Rajinikanth, Akbar  and Rajasekaran, 
2012). It is one of the alarming worldwide health problems at present leading to 
urinary tract infections, papillary necrosis and glomerular lesions (Li et al., 2012). 
World Health Organization (WHO) estimates that more than 220 million people 
worldwide have diabetes and this number is likely to double by 2030 (Aragãoa et al., 
2010). The high prevalence of diabetes as well as its long term complications has led 
to an ongoing search for hypoglycemic agents from natural sources (Nicasio, 
Santamaría, Aranda, Ortiz and González, 2005). It is significant to find evidence 
whether the aqueous extract from A. crassana leaves which are used in production of 
healthy tea can lower blood glucose in vivo.  
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Free radicals have been claimed to play an important role in affecting human 
health by causing several diseases including cancer, hypertension, heart attack and 
diabetes. These free radicals are generated during body metabolism. Exogenous 
intake of antioxidants can help the body scavenge free radicals effectively. On the 
other hand, concern about the safety of the commonly used synthetic antioxidants 
such as butylated hydroxyanisole (BHA) and tertiary butylhydroquinone (TBHQ) 
have led to increased interest on natural antioxidants which occur in plants as 
secondary metabolites (Raghuveer and Tandon, 2009). It has never been reported 
regarding to antioxidant activities of agarwood leaf extract.  
Herbal remedies are widely used for the treatment and prevention of various 
diseases and often contain highly active pharmacological compounds. There is 
increasing concern about the safety of medicinal plants and their ability to produce 
toxicity and adverse effects. Accidental herbal toxicity occurs not only as a result of a 
lack of pharmaceutical quality control in harvesting and preparation, but also because 
herbal remedies are believed to be harmless. Therefore, contrary to popular belief, the 
use of herbal remedies can pose serious health risks (Alastair and Wood, 2002). Thus, 
it is necessary that toxicity study should be done along with pharmacological activity 
study to confirm the capability in clinical use. 
The aim of this study is to investigate whether the aqueous extract of A. 
crassna leaves produces antihyperglycemic effect in rats. The data obtained from this 
experiment will provide scientific evidence showing whether the herbal tea of A. 
crassna possesses an antidiabetic activity as claimed in commercial advertisements. 
In addition, antibacterial activity of the extract was determined since bacterial 
infection is a common cause of gastrointestinal disorders and Aquilaria extract is a 
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component in a traditional Thai pharmaceutical preparation for GI illness. In the 
present study, antibacterial activity of the extract against S. epidermidis was found 
and the mechanisms underlying was proposed. In the present study, phytoconstiuents 
of this plant, such as alkaloids, cardiac glycosides, flavonoids, tannins and saponin 
were determined. Finally, phenolic content, antioxidant properties and acute toxicity 
of the extract were studied as well.  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
CHAPTER II 
LITERATURE REVIEWS 
 
2.1  Aquilaria species 
Agarwood (Aquilaria spp.) is well known for its aromatic resin. Synonyms 
were Gaharu wood and Krisana, or Mai-hom in Thai. There are about 15 species of 
Aquilaria, which belong to Thymelaeaceae family, distributed throughout tropical 
Asia. Natural distribution occurs in South and Southeast Asia, such as China 
(Hongkong, Hainan), Pakistan, India, Nepal, Bhutan, Bangladesh, Sri-Lanka, 
Cambodia, Vietnam, Laos and Thailand. The 15 species of Aquilaria are A. apiculata, 
A. baillonii, A. banaense, A. beccariana, A. brachyantha, A. cumingiana, A. filaria, A. 
hirta, A. khasiana, A.malaccensis, A. microcarpa, A. rostrata, A. sinensis, A. 
subintegra, and A. crassna. In Thailand, there are four species of Aquilaria, including 
A.crassna, A. malaccensis, A. subintegra and A. hirta. They are naturally distributed 
in central, northeast and eastern of Thailand, such as Nakhon Ratchasima, Nakhon 
Nayok, Prachin Buri, Buri Ram and Chantaburi provinces (Matsui, 2005). 
Krisana is used for the production of high valued incense, cosmetics and 
pharmaceutical products in Asia (Eurlings, Beek and Gravendeel, 2010) and their 
leaves are also cultivated as a healthy tea in South East Asia countries such as Viet 
Nam, Laos and Thailand. Having been heavily poached, nowadays Krisana has 
become endangered species. The Thai government encourages cultivating of Krisana 
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for preventing species extinction. However, it takes at least 5 years before they can 
provide precious resin. During this period, leaves of young A. crassna are used to 
produce commercial healthy herbal tea as it is believed that tea from A. crassna leaves 
has antidiabetic, antigout and antihyperlipidemia activities. Characteristics of four 
agarwood species found in Thailand are the followings. 
Aquilaria malaccensis 
A. malaccensis reaches up to 20-40 m tall and 60 cm in diameter. Young bark 
is light brown with fine hairs, older bark is smooth and whitish in color. Leaves are 
characterized by alternate, elliptic or lanceolate, 3-3.5 cm wide and 6-8 cm long with 
12-16 pairs of veins. Inflorescens are a terminal or a axillary umbel.  
 
 
Figure 2.1 A. malaccensis.(1) twig (2) flower (3) longitudinal section of flower (4) 
fruit (5) longitudinal section of fruit (Adelina, 2004).  
 
Flowers are hermaphroditic, up to 5 mm long, fragrant and yellowish green or 
white. Fruit is green in color, egg-shaped capsule and leathery exocarp with fine hairs, 
4 cm long and 2.5 cm wide. There are two seeds per fruit. Seed is blackish brown in 
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color, ovoid and densely covered with red-brown hair (Sitepu, Santoso and Turjaman, 
2011).  
Aquilaria subintegra 
A. subintegra is a small tree up 2 m tall. Leaves are acuminate, base cuneate to 
obtuse petiole pubescent or glabrous, 5-10 mm long. The flowers are white. Its 
pedicels are puberulous 6-13 mm long. The calyx-tube is 5-12 mm long. The fruit is 
elliptic. The seed is narrowly elliptic, sparsely puberulous (Santisuk, 1997).  
 
 
 
Figure 2.2 A. subintegra (A) flowers (B) leaves (Source: Forest Herbarium, 2003). 
 
Aquilaria hirta  
A. hirta is tree up to 14 m tall. Leaves are acuminate, base cuneate to obtuse or 
rounded, 6.5-14 by 2.5-5.5 cm. The flowers are white or light yellow. The pedicel are 
up to 20 mm long. The calyx-tube is 6-8 mm long. The seed is ovoid, puberulous, 
glabrescent and shortly beaked at the apex (Santisuk, 1997).  
 
  
 
 
 
 
 
 
9 
 
 
Figure 2.3 A. hirta (A) twig and iflorescence (B) flower (C) flower cutting open to 
show stamens (D) ovary (Santisuk, 1997). 
 
Aquilaria crassna 
A. crassna is an evergreen tree up to 30 meters with narrow crown and slender 
tree  (Matsui, 2005). Its bark is brownish grey, shallowly fissured and flaking in thin 
strip. Inner bark is wet with much water. Leaves are alternate, coriaceous, elliptical, 
petiole 4-5 mm, blade 7-11.5 cm long 2.5-5 cm wide. The flowers are small, pale 
blue-yellow, fragrant and fine-haired. Its pedicels are up to 0.6-0.8 cm long and 
bisexual. The fruit is 4 cm long, 2.2 cm wide, bright green and pubescent. The seed is 
glossy black, long and tail-like pubescent appendage.  
The main differences of botanical characteristics between A. crassna and A. 
malaccensis are the length of pedicels and the size of calyx-lobes. The length of 
pedicels of A. crassna is 5-10 mm larger than 2-5 mm in A. malaccensis.  
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Figure 2.4 A. crassna (A) fruiting branch (B) fruit (C) leaf seen from beneath (D) 
inflorescence (E) fruiting branch (Santisuk, 1997). 
 
The size of calyx-lobes of A. crassna is 3-4 x 2-3.5 mm large as compared to 
2-3 x 1.5 -2 mm in A. malaccensis. The calyx-lobes of A. crassna during fructification 
are much enlarged up to 15 mm. In addition, the height of A. crassna tree is 30-40 m 
as compared to 40 m in A. malaccensis. The leaf size of A. crassna is 8-16 x 2-5.5 cm 
as compared to 7-12 x 2.5-5.5 cm in A. malaccensis. Moreover, they can be 
distinguished by measuring the size of leaflet. The size of leaflet of A. subintegra is 7-
10.5 x 19-27.5 cm large as compared to 2-5.2 x 5-15 cm in A. crassna and 2.5-5 x 7-
11.5 cm in A. malaccensis and 2.5-5.5 x 6.5-14 cm in A. hirta (Matsui, 2005). 
 
2.2 Phytochemicals of Aquilaria species 
Plants have many phytochemicals which are potential sources of natural 
antioxidants, e.g. phenolic diterpenes, flavonoids, tannins and phenolic acids 
(Dawidowicz, Wianowska and Baraniak, 2006). Medicinal plants are a source of 
bioactive activity and are of great utility for developing some novel therapeutic 
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agents. The medicinal value of these plants lies in some active chemical substances 
called phytochemicals that produce a definite physiological action on the human 
body. The most important of these chemically active (bioactive) constituents of plants 
are alkaloids, tannins, flavonoids and phenolic compounds (Edeoga, Okwu and 
Mbaebie, 2005). Phytochemical studies of some species of Aquilaria have been 
reported. The presence of alkaloids, flavonoids, triterpenoids, steroids and saponins 
were revealed in A. malaccensis leaves extract (Huda, Munira, Fitrya and Salmah, 
2009). The phytoconsituents isolated from this leaves are kusunol, jinkoheremol, 
jinkohol II, α-agarofuran, (-)-10-epi-γ-eudesmol, oxo-agarospirol, 10-epi-γ-eudesmol 
and six new 2-(2-Phenylethyl) chromone compounds (Konishi, Konoshima, Shimada 
and Kiyosawa, 2002).   A. malaccensis leaves contained sesquiterpene alcohols, which 
was 10-epi-γ-eudesmol. Four new compounds were isolated from the n-butanol 
fraction of the 70% aqueous ethanolic of  A. sinensis, including aquilarisinin, 
aquilarisin, hypolaetin 5-O-β-D-glucuronopyranoside and aquilarixanthone. In 
addition, four known compounds, including mangiferin, iriflophenone  2-O-α-L-
rhamnopyranoside, iriflophenone 3-C-β-D-glucooside and iriflophenone 3,5-C-β-D-
diglucopyranoside, extracted from the ethyl acetate fraction showed an α-glucosidase 
inhibitor activity (Feng, Yang and Wang, 2011). A new spirovetivane - type 
sesquiterpene along with a known 2-(2-phenylethyl) chromone was found in the 70% 
ethanol extract of Vietnamese agarwood (Ueda et al., 2006). Three novel diepoxy 
tetrahydrochromones, oxidoagarochromone A, B, and C, were isolated from 
agarwood artificially produced by intentional wounding of A. crassna (Yagura, 
Shibayama, Ito, Kiuchi and Honda, 2005). However, phytochemical report regarding 
to the constituents of A. crassna leaves is very limited. 
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2.3 Pharmacological properties of Aquilaria species 
Aquilaria species have been used as a Thai traditional medicine for a long 
time. It is one of several ingredients in the commercial preparation Krisanaglun for 
treatment of gastrointestinal illness, such as stomach ache, diarrhea and flatulence. A. 
crassna  extract has been using as an ingredient of the Thai traditional product so 
called Ya-hom for treatment of fainting by targeting the cardiovascular system. It has 
also been reported that Ya-hom inhibited both histamine and carbachol induced 
gastric acid, pepsin and soluble mucus secretions in a dose-dependent manner. Ya-
hom had a maximum inhibition on the acid-stimulating effects of the histamine than 
that of carbachol. (Suvitayavat, Kodchawongs, Thirawarapan and Bunyapraphatsara, 
2004). However, there are many more active ingredients in Ya-hom that could be 
contribute to this action.  
Some pharmacological activities of Aquilaria species have been studied. For 
example, it has been described that the ethyl acetate fraction of the 70% aqueous 
ethanol extract from the leaves of A. sinensis has inhibitory effects against α-
glucosidase activity (Feng, Yang and Wang, 2011). Kim (1997) also reported that the 
aqueous extract of A. agallocha stems inhibits the immediate hypersensitivity reaction 
by inhibition of histamine release from mast cells. The leaves of A. sinensis which 
have been used traditionally in China for treatments of inflammation and anaphylaxis 
were found to exhibit notable analgesic, antiinflammatory (Zhou et al., 2008).  
It was claimed that agarwood (Jinkoh in Japanese) is used traditionally as a 
sedative in Asia (Okugawa, Ueda, Matsumoto, Kawanishi and Kato, 1993). 
Neuropharmacological studies have been conducted with the petroleum ether, 
benzene, chloroform, and water extracts from A. malaccensis in mice. The benzene 
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extract showed a reducing effect in spontaneous motility, a prolonging effect on 
hexobarbiturate-induced sleeping time, a hypothermic effect in terms of rectal 
temperature and a suppressive effect on acetic acid-writhing by oral administration. 
Fraction 1 of the three fractions which were obtained from the benzene extract by 
column chromatography was found to produce more positive effects on these 
neuropharmacological tests than the original benzene extract. These result suggested 
that the benzene extractable compounds of agarwood possess potent central nervous 
system depressant activities (Okugawa, Ueda, Matsumoto, Kawanishi and Kato, 
1993). The jinkoh-eremol and agarospirol were obtained from the benzene extract. 
They also gave positive effects on the central nervous system by peritoneal and 
intracerebroventricular administration. They decreased both methamphetamine and 
apomorphine-induced spontaneous motility. Therefore, jinkoh-eremol and agarospirol 
can be considered to be neuroleptic (Okugawa, Ueda, Matsumoto, Kawanishi and 
Kato, 1996). 
Recently, the underline mechanism of anti-inflammatory effect of the ethyl 
acetate extract of A. crassna has been studied using isolated human peripheral blood 
mononuclear cell. It was proposed that the anti-inflammatory effect was produced by 
inhibition of tumour necrosis factor-alpha (TNF-α) gene expression and secretion 
(Kumphune, Prompun,  Phaebuaw, Sriudwong, Pankla, and Thongyoo, 2011). In 
addition, the ethyl acetate extract of A. crassna could reduce ischemia induced injury 
and cell death in cardiac myoblast cell line (Jermsri and Kumphune, 2012). It has 
been reported that the water and ethanol extract of  A. crassna process antimicrobial 
activity against some bacteria, such as Staphylococcus aureus, Clostridium difficile, 
and Bacteroides spp. but not Escherichia coli and lactic acid bacteria including 
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Enterococcus faecalis, Bifidobacterium longum and Bifidobacterium adolescentis) 
(Kakino et al., 2012). However, the antimicrobial activity of the extract from  A. 
crassna leaves against Psuedomonas auruginosa has never been reported. 
 
2.4 Antioxidant activity of medicinal plants 
Antioxidant compounds in food play an important role as a health protecting 
factor. Scientific evidence suggests that antioxidants reduce the risk for chronic 
diseases including cancer, diabetes and heart disease. Primary sources of naturally 
occurring antioxidants are whole grains, teas, herbs, fruits and vegetables (Aiyegoro 
and Okoh, 2010). Amongst the antioxidants, several groups of polyphenols 
(anthocyanins, tannins, flavonones, isoflavones, resveratrol and ellagic acid) are 
currently used in the industry as nutraceuticals and/or functional foods (Espin, 
Conesa, Teresa and Barberan, 2007). Some antioxidant compounds are extracted from 
easy sources, such as agricultural and horticultural crops or medicinal plants. These 
antioxidant properties are due to some vitamins, terpenoids (carotenoids and essential 
oils) and phenolic compounds which are important in plants themselves for normal 
growth development and defense against infection and injury. The presence of 
phenolics in injured plants may have an important effect on oxidative stability and 
microbial safety (Tadhani, Patel and Subhhash, 2007). Additionally to their role as 
antioxidant, these compounds exhibit a wide spectrum of medicinal properties, such 
as antiallergic, antiinflammatory, antithrombotic, cardio-protective and vasodilatory 
effects (Balasundram, Sundram and Samman, 2006). Several studies have described 
the antioxidant properties of medicinal plants, food and beverages which are rich in 
phenolic compounds because of their highly redox potentials. Such compounds act as 
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reducing agents, hydrogen donors, singlet oxygen quenchers, free radical scavengers 
and as chelating agents of pro-oxidants metals (Chanwitheesuk, Teerawutgulrag and 
Rakariyatham, 2005; Tsao and Deng, 2004). It has been shown that phenolic 
antioxidants in herbs are mainly composed of phenolic acids, flavonoids and catechins 
which have capacities of quenching lipid peroxidantion, preventing DNA oxidative 
damage and scavenging reactive oxygen species.  
Testing the activity by more than one assay is desirable because different 
methods measure different characteristics of the antioxidant. Several approaches are 
used to test the antioxidants in foods and biological systems. In the present study, 
three different methods were used to determine antioxidant activity of the extract of A. 
crassna leaves as follow: 
2.4.1 2, 2-diphenyl-1-picrylhydrazyl radical scavenging capacity (DPPH) 
assay 
2, 2-diphenyl-1-picrylhydrazyl radical scavenging capacity assay is 
hydrogen atom transfer process widely used evaluate the antioxidant activity of 
reductants (plant extracts, phytochemical or pharmaceutical drugs) (Kaviarasan, Naik, 
Gangabhagirathi, Anuradha and Priyadarsini, 2007). The DPPH free radical is 
reduced to the corresponding hydrazine when it reacts with hydrogen donors 
(antioxidant) using decolouration mechanism (purple to yellow), which are monitored 
by the decrease in absorbance at 515-528 nm    (Rekha et al., 2012). 
2.4.2 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) cation radical 
scavenging (ABTS) assay 
2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) cation radical 
scavenging assay is based on the reduction of blue/green ABTS
•+ 
chromophore 
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generated from the reaction between ABTS and potassium persulphate (K2S2O8) by 
an electron-donating antioxidant. The decolourization of the ABTS
•+
 chromophore is 
measured spectrophotometrically at 734 nm. Thus the extent of decolorization as 
percentage inhibition of the ABTS
•+
 radical cation is determined as a function of 
concentration and time and calculated relative to the reactivity of a standard (Re et al., 
1999). 
2.4.3 Ferric reducing antioxidant power (FRAP) assay 
Ferric reducing antioxidant power assay is based on the reduction at 
low pH, of a colorless ferric complex to an intense blue colored ferrous complex by 
an electron donating antioxidant. The reduction of ferric complex is monitored by 
measuring the increase in absorbance at 593 nm. The FRAP assay is a robust and 
potentially useful test using inexpensive reagents and speedy reaction applicable over 
a wide concentration range (Benzie and Szeto, 1999). 
 
2.5 Diabetes mellitus 
Diabetes mellitus is a major endocrine disorder affecting nearly 10% of the 
population all over the world. Diabetes is one of the leading causes of death in 
humans if not treated. It is responsible for many complications affecting various 
organs in the body. The chronic hyperglycemic of diabetes is associated with long 
term damage, dysfunction and failure of various organs (Grover, Yadav and Vats, 
2002; Burke et al., 2003).  
2.5.1  Classification of diabetes 
Diabetes mellitus is among the most common metabolic diseases. It is 
a chronic disorder of carbohydrate, lipid and protein metabolism characterized by 
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high levels of blood glucose by defective insulin production or complete cessation of 
insulin synthesis  (Leahy, 2005).  
Insulin dependent diabetes mellitus (IDDM) or Type 1 diabetes 
accounts for about 5-15% of all cases of diabetes and occurs most often in young 
people. This is autoimmune condition, resulting in destruction of pancreatic β-cells. 
Non-insulin dependent diabetes mellitus (NIDDM) or Type 2 diabetes. 
Most diabetics are type 2. The disease is influenced by aging, obesity and peripheral 
insulin resistance. Type 2 diabetes are often obese. Type 2 diabetes is frequently 
accompanied by the lack of sensitivity of target organs to either endogenous or 
exogenous insulin. This resistance to insulin is considered to be a major cause of this 
type of diabetes (Finkel, Clark and Cubeddu, 2009). Summary of the principle 
characteristics of each type are shown in Table 2.1. 
2.5.2 Insulin 
Insulin is synthesized in significant quantities only in β-cells in the 
pancreas. Insulin stimulates glucose transport and metabolism, enhances glycogen 
synthesis and stimulates lipogenesis to promote storage of fuel for energy. It also has 
important growth-promoting actions in a variety of tissues. Insulin is a polypeptide 
composed of 51 amino acid and formed by an A chain and a B chain linked by 
disulfide bonds. The insulin mRNA is translated as a single chain precursor called 
preproinsulin, and removal of its signal peptide during insertion into the endoplasmic 
reticulum generates proinsulin. Proinsulin consists of three domains: an amino-
terminal B chain, a carboxy-terminal A chain and a connecting peptide in the middle 
known as the C peptide. Structure of proinsulin is shown in Figure 2.5. 
 
  
 
 
 
 
 
 
18 
2.5.3 Insulin secretion 
Insulin is released from β-cells by exocytosis which is initiated by the 
increase in intracellular calcium through voltage-dependent calcium channel. When 
glucose enters β-cells of pancreas, it is metabolized to ATP. The increasing of ATP 
causes a closure of ATP-sensitive potassium channels, which leads to a decreased 
potassium influx and subsequent depolarization of the β-cells membrane. Voltage-
dependent calcium channels open and result in an influx of calcium, causing 
translocation and exocytosis of secretory granules of insulin to the cell surface.  
 
Table 2.1 Summary of the main features of Type 1 diabetes and Type 2 diabetes. 
 Type 1 diabetes Type 2 diabetes 
Aetiology Autoimmune (β-cell destruction) Insulin resistance and β-cell 
destruction 
Peak age 12 years (can occur at any age) 60 years (increasingly seen at a 
young age due to obesity) 
Prevalence 0.3% Around 6% 
Presentation Osmotic symptoms (days to 
weeks), weight loss, DKA  
Patient usually slim 
Osmotic symptoms (months to 
years), diabetic complications 
Patient usually obese 
Treatment  Diet and insulin Diet, exercise (weight loss), oral 
hypoglycaemic agents, insulin 
later 
DKA, diabetic ketoacidosis (Lechago and Gould, 1997; Ajjan, 2009).  
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Figure 2.5 Structure of proinsulin (Clark, Brater and Johnson, 1992). 
 
2.5.4 Oral antidiabetic agents 
Oral antidiabetic agents available in markets include sulfonylureas, 
biguanide, α-glucosidase inhibitors and dipeptidyl peptidase-IV inhibitor. Each of 
them produce hypoglycemic effect by different mechanisms as the followings. 
2.5.4.1 Insulin secretagogues: Sulphonylurea 
The sulphonylurea group of drugs has been available for the 
last 50 years. All of them (glibenclamide, glipizide and gliclazide) have a similar 
mechanism of action that is mediated by inducing closure of the ATP-sensitive 
potassium channels. The intracellular retention of ATP-sensitive potassium changes 
the membrane potential resulting in depolarization of the β-cell and opening of the 
voltage-dependent calcium channels (Ca
2+
). This facilitates movement of Ca
2+
 into the 
cell, stimulating exocytosis of insulin into the circulation (Joshi and Joshi, 2009). 
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2.5.4.2 Insulin sensitisers: Biguanides  
Hepatic sensitivity to insulin is increased, thereby reducing 
gluconeogenesis as well as glycogenolysis, which contribute to the post-prandial 
plasma glucose lowering effects. Skeletal muscle and adipocytes undergo up-
regulation of the insulin-sensitive GLUT-4 and GLUT-1 transporters to the cell 
membranes, thereby increasing glucose uptake. Further metabolic effects include 
suppression of fatty acid oxidation as well as triglyceride lowering (Bösenberg and 
Zyl, 2008).  
2.5.4.3 α-glucosidase inhibitors: Acarbose 
The α-glucosidase inhibitors inhibit the activity of the 
glucosidase enzymes which are present in the brush border of enterocytes in the 
intestinal villi. These drugs are taken at the beginning of meals. They act by delaying 
the digestion of carbohydrates, thereby resulting in lower postprandial glucose levels 
(Finkel, Clark and Cubeddu, 2009).  
2.5.4.4 Dipeptidyl peptidase-IV inhibitor: Sitaglitin  
Incretin is a peptide that is produced in the gastrointestinal 
tract. One of these incretins is glucagon like polypeptide-1 (GLP-1). GLP-1 increases 
insulin secretion and decreases glucagon release. GLP-1 is metabolized by dipeptidyl 
peptidase-IV (DPP-IV) and has a very short half-life. Thus, DPP-IV inhibitors help 
increase insulin release in response to meals (Clayton, Stock and Cooper, 2009; 
Finkel, Clark and Cubeddu, 2009; Nolte, 2009). 
 
 
 
  
 
 
 
 
 
 
21 
2.5.5 Chemical induction of diabetes 
Streptozotocin (2-deoxy-2-(3-methyl-3-nitrosoureido)-glucopyranose) 
(STZ) is synthesized by Streptomycetes achromogenes and is used to induce both 
IDDM and NIDDM (Szkudelski, 2001). STZ is widely used to induce experimental 
diabetes in animals. The mechanism of their action in β-cells of the pancreas has been 
intensively investigated and now is quite well understood. STZ enters insulin 
secreting pancreatic β-cells through GLUT-2 and causes DNA damage and finally 
triggers pancreatic.  
 
Table 2.2 Summarized mechanism of action of antidiabetic drugs (Clayton, Stock and 
Cooper, 2009; Laurence, Bennett and Brown, 1997). 
Antidiabetic drugs Mode of action 
1. Sulphonylureas 
- Tolbutamide 
- Chlorpropamide 
- Glibenclamide 
- Stimulate insulin release from β-cell 
2. Biguanide 
- Metformin 
     -  Reduce hepatic gluconeogenesis  
     -  Slow glucose absorption from 
gastrointestinal  
     -  Increase insulin action in peripheral 
tissue 
3. α-glucosidase inhibitors 
-      Acarbose 
     -  Inhibit α-glucosidase 
 4.  Dipeptidyl peptidase-IV Inhibitor 
-      Sitagliptin  
     -  Increase incretin levels; GLP-1 and 
glucose-dependent insulinotropic 
polypeptide which     
        inhibit glucagon release 
  
  
 
 
 
 
 
 
22 
β-cells necrosis (Botolin and Mccabe, 2007). The induction of experimental diabetes 
in the rat using chemical which selectively destroys pancreatic β-cells is very 
convenient and simple to use. The range of the STZ dose is between 40 and 60 mg/kg, 
but higher doses are also used. STZ is also efficacious after intraperitoneal 
administration of a similar or higher dose, but single dose below 40 mg/kg may be 
ineffective. STZ action in β-cells is accompanied by characteristic alterations in blood 
insulin and glucose concentrations. Two hours after injection, the hyperglycemic is 
observed with a concomitant drop in blood insulin. About six hours later, 
hypoglycemic occurs with high levels of blood insulin. Finally, hyperglycemic 
develops and blood insulin levels decrease (Szkudelski, 2001). 
Although plants and herbal preparations are being used in traditional 
medicine for various ailments since ancient time, the efficacious attributes of these 
have been experimentally validated only in recent decades. Several herbs and trees 
have found potential use as antidiabetic in the folk medicine (Roy, Harris, Dennison, 
Phoenix and Singh, 2005). 
 
2.6 Staphylococcus epidermidis 
In principle, bacteria are divided into two main groups, Gram-negative and 
Gram-positive bacteria, based on their cell wall structures resulting in different Gram-
stain retention.   
Cell wall structure of Gram-negative and Gram-positive bacteria are shown in 
Figure 2.6. Normally, the cell wall Gram-positive bacteria has a peptidoglycan layer 
that is relatively thick (20-80 nm) and comprises approximately 90% of the cell wall. 
Peptidoglycan forms the outer layer of the Gram-positive bacteria cell wall and does 
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not contain lipoproteins. The cell wall of Gram-positive bacteria has teichoic acids, 
which are acidic anionic polysaccharides. Teichoic acids which contain a 
carbohydrate such as glucose, phosphate and an alcohol are bonded to the 
peptidoglycan, making them an integral part of the Gram-positive cell wall structure. 
The peptidoglycan layer of the Gram-negative cell wall is very thin (5-10 nm) and  
overlaid by an outer membrane, anchored to lipoprotein molecules in the 
peptidoglycan layer. Teichoic acids do not occur in Gram-negative bacterial cell 
walls. Rather, lipoproteins (lipids linked to protein molecules) are bonded to the 
peptidoglycan, forming an integral part of the Gram-negative bacterial cell wall. 
Additionally, there are layers of lipopolysaccharide (lipids linked to carbohydrate 
molecules), phospholipids and proteins outside the peptidoglycan layer  (Atlas, 1994).  
 
 
 
Figure 2.6 Construction of the cell wall of Gram-positive and Gram-negative bacteria 
(Mims et al., 2004). 
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Table 2.3 Natural medicines used for diabetes therapy. 
Plant Part used Dose Model used References 
Averrhoa bilimbi Linn leaves 125  mg/kg 60 mg/kg STZ rats Pushparaj, Tan and Tan, 2000 
Cichorium intybus Whole plant 125  mg/kg 50 mg/kg STZ rats Pushparaj, Low, Manikandan and Tan, 
2007 
Coriandrum sativum L. seeds 200,250 mg/kg 70 mg/kg STZ rats  Eidi et al., 2009 
Chamaemelum nobile aerial plart 20 mg/kg 20 mg/kg STZ rats Eddouksa, Lemhadria, Zeggwagha and 
Michel, 2005  
Fraxinus excelsior L.  10 mg/kg 65 mg/kg STZ rats Eddouks, Lemhadri  and Michel, 2004 
Clausena anisata  root 
leaf 
800 mg/kg 
2 g/kg 
90 mg/kg STZ rats 
150 mg/kg alloxan rats 
Ojewole, 2002 
Ananthi, Prakasam and Pugalendi, 2003 Eclipta alba 
Caesalpinia bonducella seed 300 mg/kg 150 mg/kg alloxan rats Kannur, Hukkeri and Akki, 2006 
 Bauhinia forficate  leaves 200, 400 mg/kg 60 mg/kg alloxan rats  Lino et al., 2004 
Andrographis paniculata leaf 400 mg/kg 45 mg/kg STZ rats  Dandu and Inamdar, 2009 
Adansonnia digitata Stem bark 100 mg/kg 60 mg/kg STZ rats Tanko et al., 2008 
2
4
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S. epidermidis, which belongs to Staphylococcaceae family, is an aerobic    
Gram-positive cocci, arranged in grape-like clusters. It forms white, raised, cohesive 
colonies. The regular size/diameter of S. epidermidis is approximately 0.5 to 1.5 µm.      
S. epidermidis is primarily a normal inhabitant of the healthy human skin and mucosal 
microflora. It has emerged as a common cause of numerous nosocomial infections.          
S. epidermidis as one of the most often isolated bacterial pathogens in hospitals and as 
the most important pathogen involved in nosocomial blood stream infections, 
cardiovascular infections, and infections of the eye, ear, nose, and throat. S. 
epidermidis very often becomes the major infective agent in compromised patients, 
such as drug abusers and immuno-compromised patients (patients under 
immunosuppressive therapy and premature newborns). The port of entry into the 
human body in all of these infections is usually an intravascular catheter or implanted 
device or contact lenses (Lim and Web, 2005; Ziebuhr et al., 2006; Lindsay, 2008).  
S. epidermidis infections are generally treated with vancomycin. When S. epidermidis 
is growing on an implanted device in a debilitated patient (Walker, 1999).  
2.6.1 Virulence of S. epidermidis 
The ability to form biofilm, a slimy layer with embedded 
microcolonies, is one of the most important and one of the most widespread virulence 
factors occurring in microbes. This ability can be found in bacteria living in the outer 
environment as well as in pathogens and potential pathogens of humans. The biofilm-
forming ability helps bacteria to resist the conditions of the surrounding environment. 
Biofilms grow easily on surfaces of artificial materials used for catheters and 
prosthetic devices (Stewart and Costerton, 2001) and it is estimated that biofilms are 
associated with about 65% of nosocomial infections. These infections are usually 
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chronic and difficult to treat. The higher incidence of biofilm-associated infections is 
associated with the frequent use of artificial implants and medical devices nowadays 
and bacteria most commonly isolated from these infections are those of the 
Staphylococcus genus (Deightoni and Balkau, 1990; Gelosia, Baldassarri, Deighton 
and Nguyen, 2001). The most important group of infection caused by S. epidermidis 
is infections on foreign bodies. Biofilms are often the cause for the difficulty to 
eradicate S. epidermidis infections on an indwelling device, due to an impaired 
penetration of antibiotics to the target and a decreased immune response. Numerous 
studies in recent years have clearly indicated that the ability to form thick, 
multilayered biofilms on insert surfaces, such as polymers or metals, represents a 
typical feature of many nosocomial isolates (Götz, 2002). Biofilms, in the narrower 
sense, are communities of microorganisms that stick to each other and/or to surfaces 
by the production of an extracellular matrix that mostly consists of polysaccharides 
and proteins and illustrate some of the factors involved in the biofilm formation of 
staphylococci, which proceeds in two steps. First, bacteria adhere to a surface by 
unspecific factors, such as hydrophobicity and surface charge (Vacheethasanee et al., 
1998), but also by means of cell wall teichoic acids and proteins, such as autolysins or 
cell wall-associated proteins that interfere with collagen, fibronectin or other matrix 
proteins (Hussain, Heilmann, Peters and Herrmann, 2001). Second, the initial 
adherence stage is followed by the actual accumulation of the biofilm, which is 
characterized by the production of factors that mediate bacterial cell-to-cell contacts. 
A major component of S. epidermidis biofilms is polysaccharide intercellular 
adhesion, which represents a β-1,6-linked glucose aminoglycan substituted  with 
different side groups. Moreover, it has been shown recently that S. epidermidis 
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biofilms contain, depending on the growth conditions, considerable amounts of 
extracellular teichoic acids (Sadovskaya, Vinogradov, Flahaut, Kogan and Jabbouri, 
2005). 
 
2.7  Antibiotics 
Pharmacological industries have produced a number of new antibiotics in the 
last three decades, in spite of that resistance to these drugs by microorganisms has 
also been increased. In general, bacteria have the genetic ability to transmit and 
acquire resistance to drugs, which are utilized as therapeutic agents (Chitravadivu, 
Manian and Kalaichelvi, 2009). Antibiotics have long been known to have multiple 
effects on target cells. They have been interfered with essential functions of bacteria 
and least effect to host cell. Antibiotics may have a killing effect or an inhibitory 
effect on a range of microbes.   Most antimicrobial agents used for the treatment of 
bacterial infections may be categorized according to their principal mechanism of 
action. There are 4 major modes of action (Figure 2.7): (1) inhibition of cell wall 
synthesis (2) inhibition of protein synthesis (3) inhibition of nucleic acid synthesis and 
(4) inhibition of a metabolic pathway (Page, Curtis, Sutter, Walker and Hoffman, 
2002).  
2.7.1 Drugs that inhibit bacterial cell wall synthesis 
The major structural component of bacterial cell wall is the 
peptidoglycan layer. The basic structure is a chain of 10 to 65 disaccharide residues 
consisting of alternating molecules of N-acetylglucosamine and N-acetylmuramic 
acid. These chains are then cross-linked with peptide bridges that create a rigid mesh 
coating for the bacteria. The building of the chains and cross-links is catalyzed by 
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specific enzymes (e.g., transpeptidases, transglycosylases, carboxypeptidases) that are 
members of a large family of serine proteases. These regulatory enzymes are also 
called penicillin-binding proteins (PBPs) because they can be bound by β-lactam 
antibiotics. When growing bacteria are exposed to these antibiotics, the antibiotic 
binds to specific PBPs in the bacterial cell wall and inhibits formation of cross-links 
between peptidoglycan chains. 
 
 
Figure 2.7 The Mechanisms of antibiotic drugs (Page, Curtis, Sutter, Walker and 
Hoffman, 2002). 
 
This in turn activates autolysins that degrade the cell wall, resulting in 
bacterial cell death. Thus the β-lactam antibiotics generally act as bactericidal agents.  
Vancomycin is a relatively large glycopeptide antibiotic. It is active 
against most Gram-positive bacteria, including streptococci, staphylococci and 
  
 
 
 
 
 
 
29 
enterococci. Vancomycin is a prominently bactericidal antibiotic that inhibits bacterial 
cell wall synthesis by blocking the important substrates for cell wall-synthesizing 
machinery such as the D-alanyl-D-alanine residue at the free carboxyl end of the 
pentapeptide (Figure 2.8). Therefore, it inhibits utilization of the substrates by 
glycosyltransferase to produce the nascent peptidoglycan chain. In this study, 
vancomycin was used as a positive control antibacterial agent against S. epidermidis. 
 
 
 
Figure 2.8 Vancomycin inhibits peptidoglycan synthesis (Page, Curtis, Sutter, Walker 
and Hoffman, 2002). 
 
2.7.2  Drugs that inhibit bacterial protein synthesis 
The aminoglycosides antibiotics consist of amino sugars linked 
through glycosidic bonds to an aminocyclitol ring. Streptomycin, neomycin, 
kanamycin, and tobramycin were originally isolated from Streptomyces species and 
gentamicin and sisomicin were isolated from Micromonospora species. Amikacin and 
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netilmicin are synthetic derivatives of kanamycin and sisomicin, respectively. These 
antibiotics exert their effort by passing through the bacterial outer membrane (in 
Gram-negative bacteria), cell wall and cytoplasmic membrane to the cytoplasm, 
where they inhibit bacterial protein synthesis by irreversibly binding to the 30S 
ribosomal proteins. This attachment to the ribosomes has two effects: production of 
aberrant proteins as the result of misreading of the messenger RNA (mRNA) and 
interruption of protein synthesis by causing the premature release of the ribosome 
from mRNA. The aminoglycosides are bactericidal because of their ability to bind 
irreversibly to ribosomes and are commonly used to treat serious infections caused by 
many Gram-negative rods and some Gram-positive organisms. 
Tetracyclines 
The tetracyclines are broad-spectrum, bacteriostatic antibiotics that 
inhibit protein synthesis in bacteria by binding reversibly to the 30S ribosomal 
subunits, thus blocking the binding of aminoacyl-transfer RNA (tRNA) to the 30S 
ribosome-mRNA complex. Tetracyclines (i.e., tetracycline, doxycycline, 
minocycline) are effective in the treatment of infections caused by Chlamydia, 
Mycoplasma and Rickettsia species and other selected Gram-positive and Gram-
negative bacteria. 
Oxazolidinones 
Linezolid blocks initiation of protein synthesis by interfering with the 
formation of the initiation complex consisting of tRNA, mRNA and the ribosome. 
The drug binds to the 50S ribosomal subunit, which distorts the binding site for tRNA, 
thus inhibiting formation of the 70S ribosomal subunit initiation complex. Because of 
this unique mechanism, cross-resistance with other protein inhibitors does not occur. 
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Chloramphenicol 
Chloramphenicol exerts its bacteriostatic effect by binding reversibly 
to the peptidyl transferase component of the 50S ribosomal subunit, thus blocking 
peptide elongations. 
Clindamycin 
Clindamycin blocks protein elongation by binding to the 50S ribosome. 
It inhibits peptidyl transferase by interfering with the binding of the amino acid-acyl-
tRNA complex. Clindamycin is active against staphylococci and anaerobic Gram-
negative rods but is generally inactive against aerobic Gram-negative bacteria. 
 2.7.3  Drugs that inhibit nucleic Acid Synthesis 
Quinolones 
The quinolones are one of the most widely used classes of antibiotics. 
These are synthetic chemotherapeutic agent that inhibits bacterial DNA 
topoisomerase type II (gyrase) or topoisomerase type IV, which are required for DNA 
replication, recombination and repair. The DNA gyrase-A subunit is the primary 
quinolone target in Gram-negative bacteria, whereas topoisomerase type IV is the 
primary target in Gram-positive bacteria. 
Rifampin and Rifabutin 
Rifampin, a semisynthetic derivative of rifamycin B produced by 
Streptomyces mediterranei, binds to DNA-dependent RNA polymerase and inhibits 
the initiation of RNA synthesis. Rifampin is very active against aerobic Gram-positive 
cocci, including staphylococci and streptococci. 
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 2.7.4  Drugs that inhibit bacterial metabolites 
The sulfonamides are antimetabolites that compete with p-
aminobenzoic acid, thereby preventing the synthesis of the folic acid required by 
certain microorganism. Trimethoprim is another antimetabolite that interferes with 
folic acid metabolism by inhibition dihydrofolate reductase, thereby preventing the 
conversion of dihydrofolate to tetrahydrofolate. This inhibition blocks the formation 
of thymidine, some purines, methionine and glycine. Mechanisms of each antibiotics 
are summarized in Table 2.4. 
 
2.8  Bacterial resistance to antimicrobial agents 
Bacteria either have pre-existing resistance to drugs, or they develop 
resistance after exposure to antibiotics. Misuse and overuse of antibiotics have 
contributed greatly to the increase in resistant strains of bacteria. Often, when bacteria 
acquire resistance to a certain drug from a particular class (e.g., the penicillin), the 
bacteria also acquire resistance to all other drugs in that class. Some of the many 
mechanisms of resistance are summarized as follows (Lim and Web, 2005; Mcmanus, 
1997). 
 1. The organism may acquire genes encoding enzymes, such as β-lactamases,  
that destroy the antibacterial agent before it can have an effect. 
2. Bacteria may acquire efflux pumps that extrude the antibacterial agent from 
the cell before it can reach its target site and exert its effect. 
3. Bacteria may acquire several genes for a metabolic pathway which 
ultimately  
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produces altered bacterial cell walls that no longer contain the binding site of the 
antimicrobial agent. 
4. Bacteria may acquire mutations that limit access of antimicrobial agent to 
the intracellular target site via downregulation of porin genes.  
            Some examples of drugs and their resistance mechanisms are given in      
Table 2.5. 
The mechanism of action of vancomycin is to prevent cross-linking of 
peptidoglycan by binding to D-Ala-D-Ala dipeptide of the muramyl peptide.                  
As shown in Table 2.5, most Gram-positive bacteria acquire vancomycin resistance        
by changing the target molecule D-Ala-D-Ala to D-Ala-D-lactate, resulting in             
their inability to bind to vancomycin (Epstein, 1991). In case of S. epidermidis,                
it has been reported that S. epidermidis are often resistant to antibiotics,                
including penicillin (Georgopapadakou, 1993), amoxicillin (Kawano, Shimizu,        
Saitoh, Yagi, Saito and Okamoto, 1996), methicillin (Pierre, Williamson and              
Bornet Gutmann, 1990), oxacillin (Kiri, Archer and Climo, 2002) and  linezolid 
(Almeida, Lincopan, Araujo and Mamizuka, 2012). Unfortunately, there is currently 
lack of scientific report according to their mechanism of drug resistance. Therefore, it 
would noteworthy to find the alternative agents or natural products to against this 
pathogen.
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Table 2.4 Basic Mechanisms of Antibiotic Action (Murray, Rosenthal and Pfaller, 2005).  
Antibiotic Action 
Disruption of Cell Wall Binds PBPs and enzymes responsible for peptidoglycan synthesis 
Penicillin 
Cephalosporin 
Cephamycin 
Carbapenem 
Monobactam 
β-lactam/β-lactamaseinhitor Binds β-lactamases and prevents enzymatic inactivation of β-lactam 
Vancomycin Inhibits cross-linkage of peptidoglycan layers 
Isoniazid Inhibits mycolic acid synthesis 
Ethionamide 
Ethambutol Inhibits arabinogalactan synthesis 
Cycloserine Inhibits cross-linkage of peptidoglycan layers 
Polymyxin Inhibits bacterial membranes 
Bacitracin Inhibits bacterial cytoplasmic membrane and movement of peptidoglycan 
precursors 
Inhibition of Protein Synthesis Produces premature release of aberrant peptide chains from 30S ribosome 
Aminoglycoside  
Tetracycline Prevents polypeptide elongation at 30S ribosome 
Oxazolidinone Prevents initiation of protein synthesis at 50S ribosome 
 
 
3
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Table 2.4 Basic Mechanisms of Antibiotic Action (Continued).  
Antibiotic Action 
Inhibition of Protein Synthesis Prevents polypeptide elongation at 50S ribosome 
Macrolide  
Clindamycin 
Streptogramins 
Inhibition of Nucleic Acid Synthesis Bind α subunit of DNA gyrase 
Quinilone  
Rifampin Prevents transcription by binding DNA-dependent RNA polymerase 
Rifabutin 
Metronidazole Disrupts bacteria DNA (is cytotoxic compound) 
Antimetabolite Inhibits dihydropteroate synthase and disrupts folic acid synthesis 
Sulfonamide 
Dapsone Inhibits dihydropteroate synthase 
Trimethoprim Inhibits dihydrofolate reductase and disrupts folic acid synthesis 
DNA, Deoxyribonucleic acid; PBPs, penicillin-binding protein; RNA, ribonucleic acid. 
3
5
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Table 2.5 Mechanism of resistance to antimicrobial agents (Luvira, 2006). 
Antimicrobial 
agents 
Mode of Action Resistance mechanisms 
β-lactams Inhibit cell wall synthesis, 
Cell division 
β- lactamases, altered 
penicillin binding protein, 
altered GNB outer-membrane 
porins, active efflux 
Glycopeptides 
(vancomycin, 
cycloserine) 
Inhibit cell wall division Altered target site 
Aminoglycosides Inhibit protein synthesis             
(bind to30s ribosome) 
Aminoglycoside-modifying 
enzyme, 
Decreased membrane 
permeability, active efflux 
Macrolides Inhibit protein synthesis              
(bind to 50s ribosome) 
Altered target, enzymatic 
inactivation, active efflux 
Tetracycline Inhibit protein synthesis             
(bind to 30s ribosome) 
Efflux, altered target, 
enzymatic inactivation, 
decreased permeability 
Chloramphemcol Inhibit protein synthesis             
(bind to 50s ribosome) 
Chloramphenicol 
acetyltransferase, active efflux 
Rifampin Inhibits nucleic acid synthesis Altered target, decreased 
permeability of membrane 
 
Sulfonamides 
Trimethoprim 
Inhibit folic acid synthesis Altered target 
 
 
  
 
 
 
 
 
 
 
CHAPTER III 
MATERIALS AND METHODS 
 
3.1 Plant material 
      The leaves of young A. crassna (2-3 year old) were collected from a 
cultivated field in Nakhon Ratchasima province, Thailand. The plant was identified 
by a botanist, Dr. Paul J. Grote, School of Biology, Suranaree University of 
Technology (SUT) and specimen of the plant has been kept at School of 
Pharmacology, SUT. The voucher specimen number is Pharm-Chu-005. 
The leaves were oven dried at 50 C, and then cut into small pieces. Dried 
leaves (24 g) were extracted in boiling water (400 ml) for 30 min twice. The pooled 
extracts were filtered and concentrated at 40 C using a rotary evaporator under low 
pressure. The residue was freeze-dried in a lyophilizer. The extract with a total yield 
of 14.2% was stored at -20 C until used.  
 
3.2 Phytochemical screening 
Phytochemical screening procedures were carried out according to the 
standard methods previously reported (De et al., 2010; Yadav and Agarwala, 2011). 
Qualitative phytochemical compositions of the crude extract of A. crassna leaves 
were determined for the presence of alkaloids, flavonoids, tannins, saponins and 
cardiac glycosides. 
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3.2.1 Test for alkaloids 
Alkaloids were tested by Mayer’s reagent (HgCl2, 13.6 g, KI, 5 g in 
100 ml of distilled water), Dragendorff’s reagent (bismuth nitrate, 8 g; nitric acid 
30%, 12 ml; and potassium iodide, 27.2 g in 100 ml of distilled water), Hager’s 
reagent (saturated aqueous solution of picric acid), Wagner’s reagent (iodine crystal 
1.27 g, potassium iodide 2.0 g in 100 ml of distilled water) and tannic acid (5% w/v). 
The formation of cream color precipitate in Mayer’s test, reddish brown precipitate 
with Dragendorff’s reagent and Wagner’s reagent, yellow precipitate in Hager’s test 
and buff precipitate with tannic acid solution were regarded as positive for the 
presence of alkaloids. 
3.2.2 Test for flavonoids  
Existence of flavonoids in the extract was examined using Shinoda test 
by adding 1 to 2 pieces of magnesium ribbon followed by a few drops of concentrated 
hydrochloric acid. Appearance of pink scarlet color indicated the presence of 
flavonoids. 
3.2.3 Test for tannins 
The presence of tannin was determined by ferric chloride test, gelatin 
test and vanillin hydrochloride test. The extract was dissolved with distilled water and 
added a few drop of ferric chloride solution (FeCl3 3%), 1% gelatin salt solution     
(1% gelatin containing 10% NaCl) or vanillin hydrochloride reagent (1:1 v/v of 1% 
vanillin in methanol and 8% HCl). The extract was considered to have tannins when 
blue green color, white and purple red precipitates were formed with ferric chloride 
test, gelatin test and vanillin hydrochloride test, respectively. 
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3.2.4 Test for saponins  
The extract was added to 1 ml of distilled water, shaken vigorously to 
froth and then allowed to stand for 30 min. The formation of stable foam was taken as 
an indication for the presence of saponins. 
3.2.5  Test for cardiac glycosides  
The presence of unsaturated lactone ring was analysed by Kedde’s 
test. Kedde’s reagent (2% 3,5 dinitrobenzoic acid in methanol) was added to the 
extract followed by a few drops of 1 N KOH. Production of purple color indicated a 
positive result. Test for deoxy sugar was conducted by adding 1 ml of glacial acetic 
acid containing trace amount of ferric chloride. 1 ml of concentrated H2SO4 was 
carefully added by the side of test tube. A brown ring at the interface indicated a 
positive result. Liebermann’s test was performed to examine steroid nucleus. A few 
drops of acetic anhydride were added to the extract followed by a few drops of 
concentrated sulfuric acid. A color change from violet to blue to green indicated the 
presence of steroid nucleus of glycoside. All of positive results from these three tests 
are required for the presence of cardiac glycoside. 
 
3.3      Determination of total phenolic compounds 
The amount of total phenolic compounds was measured by a method 
described by Matthaus (2002). In brief, 5 mg of the extract was dissolved in 1 ml of 
distilled water. A 100 l aliquot of this mixture was added to 2 ml of 2% Na2CO3 
followed by 100 l of Folin-Ciocalteau reagent in methanol (1:1 v/v). After 30 min of 
incubation, the absorbance was measured at 750 nm. The concentration was 
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calculated using gallic acid as a standard. The results were expressed as milligrams 
gallic acid equivalents (GAE) per gram extract.  
 
3.4      Determination of antioxidant activity 
3.4.1  Scavenging effects on DPPH radicals 
To measure antioxidant activity, the 2,2-diphenyl-1-picrylhydrazyl 
hydrate (DPPH) radical scavenging assay was carried out according to the procedure 
described previously (Bor et al., 2006). The crude extract (100 l; final concentration 
range from 0-50 g/ml) was added to 4.0 ml of 50 M DPPH in methanolic solution 
and the final volume was adjusted to 5.0 ml with water. After vortexing, the mixture 
was incubated for 30 min in the dark at room temperature. The decrease in 
absorbance at 517 nm was measured using a spectrophotometer. Antioxidant activity 
was expressed as IC50, which was deﬁned as the concentration of the extract required 
to inhibit the formation of DPPH radicals by 50%.  
3.4.2 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid (ABTS) 
assay 
ABTS radical scavenging activity of extract was carried out according 
to the procedure described previously (Re et al., 1999). ABTS radical cation 
(ABTS
•+
) was produced by the reaction between 5 ml of 14 mM ABTS and 5 ml of 
4.9 mM potassium persulfate (K2S2O8). The resulting solution was stored in the dark 
at room temperature for 16 hr. Before use, this solution was diluted with ethanol to 
give an absorbance of 0.700 ± 0.020 at 734 nm. The plant extract (50 l) at various 
concentrations were added to 950 l of ABTS+ solution and mixed thoroughly. The 
reaction mixture was allowed to stand at room temperature for 6 min, the absorbance 
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was measured at 734 nm and compared to the standard butylated hydroxytoluene 
(BHT).  
3.4.3 Ferric reducing antioxidant power (FRAP) assay 
The FRAP assay was conducted according to Dordevic et al. (2010) 
with minor modification. Briefly, the FRAP reagent consists of 10 mM TPTZ (2,4,6-
tripyridyl-striazine) in 40 mM HCl, 20 mM FeCl3, and 300 mM acetate buffer (pH 
3.6) in proportions of 1:1:10 (v/v/v). 50 l of the sample was added to 1.5 ml of 
FRAP reagent (freshly prepared and warmed to 37 C before use). The absorbance 
was measured at 593 nm using a UV spectrophotometer after 4 min of incubation. A 
standard curve was constructed using FeSO4 solution. The results were expressed as 
mol Fe2+/mg dry weight of plant material. All measurements were carried out in 
triplicate and the mean values were calculated. 
 
 3.5 Acute toxicity in mice 
Male and female mice (weighing 25-35 g) were used for acute toxicity. The 
acute toxicity performed in this experiment was conducted by following the OECD 
guidelines for Testing of Chemicals (2001). The A. crassna aqueous extract was 
prepared in the concentration of 200 mg/ml and 750 mg/ml by dissolving in distilled 
water for dosing group of 2,000 and 15,000 mg/kg body weight respectively, which 
was calculated based on their body weight after fasting.  The mice were fasted 
overnight for 16 h prior to dosing (n = 10; 5 of each sex per group). Food was 
continuously withheld for 3-4 h after administration, whereas water was provided ad 
libitum. All mice were monitored for clinical signs of toxicity at 0.5, 1 and 3 h after 
oral administration of the extract and once daily thereafter for 14 days. The following 
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toxicity signs and symptoms were examined: skin, fur, eyes and mucous membranes 
evaluation, autonomic effects (e.g., salivation), central nervous system effects 
(tremors and convulsions), and changes in the level of activity, posture, strength and 
bizarre behavior. Weekly changes in body weight were examined. The animals were 
sacrificed on day 14 by lethal dose of sodium pentobarbital. The organs and tissues 
were examined macroscopically for toxicant-induced changes. Internal organ (heart, 
lung, liver, spleen, testes, ovaries and uterus) were removed and gross 
histopathological examinations were performed. 
 
3.6      Antibacterial assays 
 3.6.1 Disc diffusion assay 
The antibacterial activity of the crude extract was assayed against                    
S. epidermidis (obtained from Thailand Institute of Scientific and Technological 
Research; TISTR 518) using disc diffusion method described by Rabe and Van 
Staden (1997). Briefly, 100 l of bacteria (108 CFU/ml) was spread onto the Mueller-
Hinton agar plate. The extract (2, 4 and 6 mg) was applied to filter paper discs 
(Whatman No. 1, 6 mm diameter) and then placed on the previously inoculated agar 
plate. After 24 h of incubation at 37 C, clear inhibition zones around the discs 
indicated the presence of antibacterial activity. The assay was carried out in triplicate. 
Vancomycin (30 g) was used as a positive control. 
3.6.2 Determination of minimum inhibitory concentration (MIC) and  
minimum bactericidal  concentration (MBC)  
Determination of the minimum inhibitory concentration (MIC) against 
S. epidermidis (104 CFU/ml) was conducted by a two-fold serial dilution method. 
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MIC was considered as the lowest concentrations of the agents that yielded no visible 
growth of microorganisms after 24 h of incubation at 37 C. The MBC determination 
was carried out by subculturing 100 l from each tube from the MIC assay onto fresh 
substance-free MH agar plates. The MBC was deﬁned as the lowest concentration of 
agent that produced no growth of subcultures. 
3.6.3 Scanning electron microscopy (SEM) 
The SEM study was performed on S. epidermidis treated with MIC of 
the extract of A. crassna leaves. S. epidermidis was cultured to reach mid-log phase in 
mueller hinton broth (MHB) before use. Treated cells were prepared and the 
morphological changes were observed. The bacterial samples were washed five times 
with fresh media and then fixed with 2.5% glutaraldehyde in phosphate buffer (pH 
7.2) at 4 C for 1 h, washed three times with phosphate buffer for 10 min and fixed 
with 1% osmium tetraoxide for 2 h. This was followed by three washings in 
phosphate buffer for 10 min and subsequently dehydrated in a series of ethanol 
concentrations (30%, 50%, 70%, 90% and 95%), for 15 min each. The samples were 
subjected to 100% ethanol and CO2 to achieve the critical point and then coated with 
gold ion in a pressure metallic chamber. At the end of the process, the samples were 
submitted for analysis by SEM. 
3.6.4 Transmission electron microscopy (TEM) 
Cellular damage of bacteria was examined using TEM. Bacterial cells 
treated with vehicle, vancomycin and the extract of A. crassna leaves were harvested 
after 24 h of incubation and fixed in 2.5% glutaraldehyde in 0.1 M phosphate buffer, 
for 2 h. The cells were washed three times with 0.05 M phosphate buffer (pH 7.2) and 
postfixed for 2 h with 1% osmium tetroxide in 0.1 M phosphate buffer (pH 7.2) at 
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room temperature. The cells were washed twice in phosphate buffer. The cells were 
dehydrated through serial graded concentrations of ethanol (twice in 35, 70, 95 and 
100% ethanol, respectively, for 15 min), then infiltrated and embedded in spurr’s 
resin. Ultrathin sections were cut with a diamond knife using an ultramicrotome and 
then mounted on bare copper grids. They were stained with 2% uranyl acetate and 
lead citrate. Microscopy was performed with Tecnai G2 20-Twin at Suranaree 
University of Technology. 
3.6.5 Biofilm assay 
The inhibitory effect of the extract on biofilm formation was examined 
by microscopic analysis. A culture of S. epidermidis was prepared in tryptic soy broth 
(TSB) at 37 C for 24 h. 30 l aliquots of the culture were pipetted into each well of 
24-well plates in the presence of 3 ml TSB and incubated at 37 C for 24 h to form 
biofilm. Thereafter, medium was replaced with fresh medium containing the extract 
of A. crassna leaves or vancomycin. After incubation of another 24 h, the medium 
was removed and each well was gently washed three times with phosphate buffer 
saline (PBS). The inhibitory effect on biofilm formation was observed by phase 
contrast microscopy. 
 
3.7  Determination of antihyperglycemic activity 
 3.7.1 Induction of diabetes  
In this study, adult male Wistar-Albino rats (200-250 g) were followed 
in accordance with guidelines of the Committee on Care and Use of Laboratory 
Animal Resources, National Research Council of Thailand. The procedures of the 
experiment was performed in accordance with the advice of the Institutional Animal 
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Care and Use Committee, Suranaree University of Technology, Nakhon Ratchasima, 
Thailand. 
Each animal were housed in a cage and fed with standard pellet diet 
and water. Prior to experimental treatments, animals were fasted overnight. Diabetes 
was induced by the intraperitoneal injection of STZ, dissolved in citrate buffer (0.1 
M, pH 4.5). The first day after STZ administration (65 mg/kg), rats were given 5% 
glucose solution orally. Three days after the injection, the blood glucose levels were  
measured and the animals with blood glucose levels above 200 mg/dl were  
considered to have diabetes. Steady diabetes were confirmed by measuring blood 
glucose values before starting an experiment. Five animals were used for each group. 
The extracts were given orally using oral gastric gavages to the fasted animals. Blood 
samples were collected from the tip of tail. 
3.7.2 Experiment design 
Male Wister rats were divided into 5 groups and each group included 5 
rats: Group I (NC) normal control rats received sterile water. Group II (DM); diabetic 
control rats received sterile water. Group III; diabetic rats treated with glibenclamide 
tablets 10 mg/kg; Group IV (DM+Extract); diabetic rats treated with the A. crassna 
extract 250 mg/kg; Group V (DM+Extract); diabetic rats treated with the A. crassna 
extract 1000 mg/kg. 
 3.7.3 Sample collection 
Body weight and blood glucose analyses were done on 5th, 10th and 
15
th
 day. Blood samples were collected from tail vein. Blood glucose levels were 
determined using Glucometer Accu-Chek Performa glucose test strips (Roche 
Diagnostics, USA). 
  
 
 
 
 
 
 
46 
3.7.4  Histological examinations 
After taking blood samples, all animals were sacrificed and their  
pancreases were removed. The pancreases were cleaned with 0.85% NaCl solution 
and fixed with 10% neutral buffered formaldehyde. Then, tissues were dehydrated in 
serial ethanol solution (95%, 100%) and acetone. Tissue samples were cleaned with 
xylene. The tissues were infiltrated with molten paraffin at 65
 
ºC and embedded in 
paraffin block. Tissues were sectioned of 5 µm thickness. The sections were mounted 
onto slides using gelatin coating solution. The sections were dried at 56 ºC for 45 min 
in a hot air oven. Tissue sections were deparaffined in xylene. Tissue sections were 
hydrated with serial ethanol solution (100%, 95%). The sections were washed in 
running tap water. Sections were stained with haematoxylin for 10 min and washed in 
running tap water. The sections were stained with eosin for 10 min. Stained sections 
were dehydrated with serial ethanol solution (95%, 100%). The sections were 
immersed in acetone and xylene. The stained sections on the slides were covered with 
cover slip. The photomicrographs of each tissue section were observed under 
microscope (model CX31, Olympus, Tokyo, Japan). 
 
3.8     Statistical analysis 
All experimental results were expressed as means ± standard deviation and  
analyzed by one way ANOVA followed by Student-Newman-Keuls test. The results 
with p value < 0.05 were considered as statistically significant differences. 
 
  
  
 
 
 
 
 
 
 
 
CHAPTER IV 
RESULTS 
 
4.1 Phytochemical screening   
 
Figure 4.1   A. crassna leaves (A) and dried extract (B). 
 
The results of the phytochemical analysis of the leaf of  A. crassna are shown 
in Table 4.1. The results obtained showed the presence of flavonoids, tannins, 
saponins, cardiac glycosides and an absence of alkaloids.  
 
4.2 The total phenolic compounds 
Total phenolic compound of plant extract, using water as solvent is shown in 
Table 4.1.  The result for total phenolics was expressed as gallic acid equivalent (mg 
GAE/g). The total phenolic of the leaf extract was 176.61±24.46 mg GAE/g extract 
(n=3).  
A B 
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Table 4.1 The phytochemical compounds and total phenolics content of the aqueous 
extract. 
Phytochemical compounds Presence mg GAE/g extract 
Tanins + ND 
Flavonoids + ND 
Saponins + ND 
Cardiac glycosides + ND 
Alkaloids - ND 
Total phenolic + 176.61±24.46 
+: Present, -: Absent, ND: not determined 
 
4.3 Antioxidant activity  
The result of radical scavenging capacities which were determined by DPPH, 
ABTS and FRAP scavenging methods are shown in Table 4.2. The DPPH scavenging 
effect of  A. crassna exhibited a potential free radical scavenging activity. Maximum 
scavenging activity (91.52%) was observed at 50 µg/ml concentration and the half 
inhibition concentration (IC50) of A. crassna leaves extract and ascorbic acid were 
found to be 7.25±2.05 µg/ml and 1.33±0.08 µg/ml respectively. The results indicated 
that the aqueous extract of A. crassna decrease in the DPPH radical may be due to the 
scavenging ability of A. crassna. Free radical scavenging activity was increased with 
an increasing concentration. 
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The results of ABTS radical scavenging activity of the extract and standard 
(BHT) were present in Table 4.2. The scavenging activity of  A. crassna leaves 
extract against ABTS radical was in a concentration dependent manner. The 
percentage inhibition of the extract (96.60%) was observed at 1,200 µg/ml 
concentration. The IC50 values of the extract and BHT were 218.93±29.77 µg/ml and 
83.09±0.45 µg/ml, respectively.  
Ferric reducing antioxidant power (FRAP) is shown in table 4.2. The FRAP 
value, expressed in µmol of Fe
2+
/ mg dried extract, was found in A. crassna leaves 
extract at 1.18±0.07 µmol of Fe
2+
/ mg dried extract.  
 
Table 4.2 Radical scavenging activities and reducing power of the aqueous extract of 
A. crassna leaves. 
  Methods  
 DPPH radical ABTS FRAP 
 (IC
50
: µg/ml) (IC
50
: µg/ml) (µmol Fe
2+
/mg 
dried extract) 
A. crassna leaf extract 7.25 ± 2.05 218.93 ± 29.77 1.18 ± 0.07 
Ascorbic acid 1.33 ± 0.08 - - 
Butylated hydroxytoluene 
(BHT) 
- 83.09 ± 0.45 - 
     Values are expressed as means ± standard deviation (n=3). 
 
4.4 Acute oral toxicity of A. crassna leaf extract in mice 
The acute toxicity of aqueous A. crassna leaf extract in mice is summarized in 
Table 4.3. The results showed that with the doses of 2,000 and 15,000 mg/kg body 
weight of the extract, all treated mice did not exhibit abnormal signs of toxicity or 
  
 
 
 
 
 
 
50 
deaths. Normal increase in body weight and none of gross pathological lesions were 
observed on the control and treated mice. 
  
4.5     Antibacteria activity of A. crassna 
By disc diffusion assay, it was found that the extract can inhibit growth of S. 
epidermidis and S. aureus (Table 4.4) at 2, 4 and 6 mg. Whereas, vancomycin was 
used as a positive control. The results showed that the extract possessed less potency 
than vancomycin (30 µg). The extract did not inhibit the growth of Pseudomonas 
aeruginosa and Bacillus subtilis. 
 
The MIC values of the extracts obtained using the micro-dilution method as 
shown in Table 4.5. The leaf extracts of A. crassna gave MIC and MBC values at 6 
and 12 mg/ml against S. epidermidis, respectively, when compared with control cell 
after 24 h of incubation at 37 C. The assay were carried out in triplicate. 
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Table 4.3 Acute oral toxicity of the extract of A. crassna leaves in mice. 
treatment 
(mg/kg) 
sex 
Body weight (g) 
Mortality 
Symptoms 
Of toxicity 
Gross 
pathology 
Day 1 Day 8 Day 15 
0  33.20±0.84 37.06±1.52 41.00±1.73 0 None Normal 
2000 Male 32.80±1.30 37.20±0.84 41.00±1.00 0 None Normal 
15000  34.40±1.14 39.80±0.84 43.20±0.84 0 None Normal 
0  28.40±1.67 30.80±2.17 34.00±1.58 0 None Normal 
2000 Female 28.00±1.22 30.00±1.22 33.20±1.64 0 None Normal 
15000  28.80±1.30 31.80±1.30 34.00±1.00 0 None Normal 
Values are expressed as means ± standard deviation (n=5); р˃0.05 compared to control. 
5
1
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Table 4.4 Antibacterial activity of the aqueous extract of A. crassna leaves.  
Microorganisms  
Diameters of inhibitions zone (mm)  Positive control 
A. crassna extract (mg) Vancomycin 
 (30 µg) 
Kanamycin 
 (10 µg) 2 4 6 
Gram positive bacteria  
     
Staphylococcus aureas  10.0±1.0 11.0±1.1 13.0±1.3 18.0±1.0 - 
S.  epidermidis  12.0±1.0 15.0±0.4 18.0±1.0 21.0±1.0 - 
Bacillus subtilis  n.i. n.i. n.i. 24.0±0.57 - 
Gram negative bacteria  
Pseudomonas aeruginosa  
 
n.i. 
 
n.i. 
 
n.i. 
 
- 
 
20.0±0.3 
n.i.; no inhibition zone, Data are means ± standard deviation (n=3). 
5
2
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Table 4.5 The MIC and MBC values of aqueous extracts against S. epidermidis. 
S. epidermidis 
A. crassna Vancomycin 
(mg/ml) (µg/ml) 
MIC 6 1.5 
MBC 12 3 
 
4.6  Scanning Electron Microscopy (SEM) 
S. epidermidis was treated with the extract at MIC (6 mg/ml) and incubated at 
37 °C for 24 h. SEM analyses were performed and compared to untreated and 
vancomycin-treated groups. Control bacteria in the absence of the extract showed 
regular morphology (Figure 4.2A), whereas cells treated with vancomycin (Figure 
4.2B) and the aqueous extract of A. crassna leaves (Figure 4.2C) appeared swollen 
and distorted after 24 h of incubation. 
 
Figure 4.2 Scanning electron micrographs of S. epidermidis treated with A. crassna 
leaves extract. The swollen cells (arrows) were observed after treated for 24 h with 
vancomycin (B) and the extract (C) compared with regular shape of control (A). 
Enlargement: ×10000. 
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4.7  Observation of cellular damage by TEM  
Electronmicroscopic investigations clearly showed that the bacterial cells 
treated with crude A. crassna leaves extract caused damage to the ultrastructure of S. 
epidermidis cells compared with untreated control. Figure 4.3 showed that cell wall 
and cytoplasmic membrane of S. epidermidis cell were damaged after the addition of 
the extract. Similarly, some of vancomycin treated bacterial cells showed 
morphological damages such as cell shape distortion,  indicating that vancomycin 
was positive control and had effect on the cell wall and irregular morphology.  
 
Figure 4.3 Transmission electron micrographs of S. epidermidis treated with A. 
crassna leaves extract. (A), (B) and (C) are overview of the untreated cells and cells 
treated with vancomycin and the extract, respectively (Enlargement: ×15000). 
Bacterial cells with irregular shape were seen in both treated groups. Damaged cell 
walls (arrows) were observed after 24 h of incubation with vancomycin (E) and the 
extract (F) compared with control (D). Enlargement: ×43000.  
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4.8  Effects of the extract on biofilm formation  
Crystal violet staining of surface-attached cells by microtiter plate assay is a 
popular and convenient method for quantitative detection of bacterial biofilm 
formation; however direct microscopic observation is strongly recommended to 
confirm the data from staining analysis (Merritt, Kadouri and O’Toole, 2011). Due to 
the absorption of the A. crassna leaf extract at 595 nm, in the present study the effect 
on biofilm formation was investigated by microscopic analysis which gave more 
accurate information. The phase contrast microscopic images (Figure 4.4) showed 
that S. epidermidis formed vast empty regions on surface with a few clusters of cells 
and scattering of single cell when treated with the extract and vancomycin. 
 
 
Figure 4.4 Microscopic images on biofilm formation of S. epidermidis treated with A. 
crassna leaf extract. Cells treated with vancomycin (B) or the extract (C) formed less 
biofilm compared to control sample (A). Enlargement: ×400. 
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4.9  Determination of antihyperglycemic activity 
4.9.1  Effect of A. crassna extract on body weight  
  Body weights of rats in the 5 groups were shown in Figure 4.5. After 
administered with STZ, rat body weights in all groups except for the glibenclamide-
teated group significantly decreased compared to normal control (0 day; before 
treatment). At the 5
th
, 10
th
 and 15
th
 day of treatment, the body weights of 
glibenclamide rats, but not the A. crassna treated rats, significantly increased 
compared to diabetic-vehicle control group (р<0.05). 
 
 
Figure 4.5 Body weight changes of rats, Values are mean ± SD (n=5). N group: 
normal control rats; D group: diabetic rats; D+glib group: glibenclamide treated 
diabetic rats; D+AC group: A. crassna treated diabetic rats. *р<0.05 statistically 
significant difference from normal control. #р<0.05 statistically significant difference 
from diabetic control. 
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 4.9.2 Effect of A. crassna leaf extract on blood glucose in experimental 
groups 
  The mean blood glucose of the diabetic rats after STZ induction was 
significantly higher than that in normal control rats (Figure 4.6). After 10 and 15 days 
of treatment, blood glucose level of glibenclamide-treated diabetic rats were 
significantly (р<0.05) decreased compared with diabetic vehicle control rats. 
However, in accordance with its effect on body weight, the extract did not decrease 
blood glucose level of diabetic rats after the same duration of treatment even with 
high concentration (1000 mg/kg). 
 
 
Figure 4.6 Changes of blood glucose of rats, Values are mean ± SD (n=5). N group: 
normal control rats; D group: diabetic rats; D+glib group: glibenclamide treated 
diabetic rats; D+AC group: A. crassna treated diabetic rats. *р<0.05 statistically 
significant difference from normal control. #р<0.05 statistically significant difference 
from diabetic. 
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 4.9.3  Histopathological examination  
Histopathological examination of pancreas exhibited normal 
appearances of islets of Langerhans in normal control rats (Figure 4.7A). 
Streptozotocin induced diabetes in rats by damaging the islets of Langerhans as 
shown in Figure 4.7B. This effect was reversed when animals were treated with 
glibenclamide for 15 days (Figures 4.7C). In contrast, the islet cells of diabetic rats 
receiving the extract of A. crassna leaves at 250 (Figure 4.7D) and 1,000 mg/kg 
(Figure 4.7E) appeared distorted and damage similar to those of diabetic vehicle 
control group (Figure 4.7B). 
 
 
Figure 4.7 Histopathological observations of A. crassna and glibenclamide treated 
pancreas in streptozotocin induced diabetic rats stained by haematoxylin and eosin. 
(A) Normal control, (B) Diabetic control, (C) Diabetic+glibenclamide 10 mg/kg, (D) 
Diabetic+A. crassna 250 mg/kg, (E) Diabetic+A. crassna 1000 mg/kg. Enlargement: 
×400. 
  
 
 
 
 
 
 
 
 
CHAPTER V 
DISCUSSION AND CONCLUSIONS 
 
 In general, type and level of biological activity exhibited by any plant 
material depends on many factors, including the plant part, geographical source, soil 
conditions, harvest time, moisture content, drying method, storage conditions and 
post-harvest processing. For example, the relatively high temperatures that can be 
generated during tissue grinding can denature chemical constituents and the 
extraction solvent, time period and temperature can affect the level and composition 
of secondary metabolites extracted from plant tissues (Wendakoon, 2012). Thus, 
phytochemical constituents of the extract from the same plant may be different from 
laboratory to laboratory. In this study, hot water was chosen as an extraction solvent 
to simulate the method used for healthy tea consumption. The aqueous extract is 
widely accepted for crude extraction of phytochemicals from medicinal plants 
especially for therapeutic applications. The aqueous extract of A. crassna obtained 
from this study consisted of tannins, flavonoids, saponins and cardiacglycosides. 
Alkaloids are theoretically lipophilic, therefore they were not detected. 
A various phytochemical constituents are known to have beneficial 
importance in medicinal sciences (Mithraja, Antonisamy, Mahesh1, Paul and Jeeva, 
2011; Abraham and Aeri, 2012). Each group of phytochemical compounds shows 
different biological effects. For example, flavonoids which are the major group of 
phenolic compounds are reported to have antimicrobial, antiviral, antioxidants and
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spasmolytic activity. Tannins which are water-soluble polyphenols are also known to 
possess antimicrobial agents. The growth of many fungi, yeasts, bacteria and viruses 
was inhibited by tannins (Chung, 1998). Phytotherapeutically tannin-containing 
plants are used to treat nonspecific diarrhoea, inflammations of mouth and throat and 
slightly injured skins (Westendarp, 2006). There is evidence showing that saponins 
can be therapeutically used in hypercholesterolemia, hyperglycemia, antioxidant, 
anticancer, anti-inflammatory and weight loss (Hasan et al., 2009; Maobe, Gatebe 
and Gitu Rotich, 2013). Moreover, it is a bioactive antibacterial agent of several 
plants (Mandala, Babub and Mandal, 2005; Manjunatha, 2006). Cardiac glycosides 
are naturally cardioactive drugs used in the treatment of congestive heart failure and 
cardiac arrhythmia (Newman, Yang, Pawlus and Block, 2008).  
Phenolic compounds are constituted in one of the biggest and widely 
distributed groups of secondary metabolites in plants (Scalbert and Williamson, 
2000). The phenolic compounds are very important constituents in plants because of 
their scavenging ability of their hydroxyl groups and preventing decomposition of 
hydroperoxides into free radicals (Maisuthisakul, Suttajit and Pongsawatmanit, 2007). 
It has been shown that phenolics are active in curing kidney and stomach problems as 
well as helpful as anti-inflammatory in action (Zhu, Phillipson, Greengra, Bowery 
and Cai, 1997). The total phenolic content in the extract in this study was 176.61 mg 
GAE/g which is considered as moderate level. 
There are several lines of evidence showing positive correlation between total 
phenolic content and antioxidant properties (Velioglu,Mazza, Gao, Oomah., 1998; 
Moller, Lindberg, Aaltonen and Skibsted, 1999; Turkoglu, Duru, Mercan, Kivrak and 
Gezer, 2007). It is expected that the extract may have some beneficial antioxidant 
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activities similar to other plants. ABTS, DPPH and FRAP assays are widely used to 
determine the antioxidant capacity in plant extracts because of their simplicity, 
stability and accuracy (Reddy, Sreeramulu and Raghunath, 2010). The Folin-
Ciocalteau method is a rapid and widely used assay to investigate the total phenolic 
content. This method is based on an oxidation-reduction reaction in which phenolic 
compounds are oxidized with simultaneous reduction of a phosphotungsten-
phosphomolybdate complex in an alkaline medium, reacting blue (Gzella, Makuch 
and Matlawska, 2012). However, it is known that different phenolic compounds have 
different responses in the Folin-Ciocalteau method (Kahkonen et al., 1999). In recent 
years, phenolic compounds from natural sources have been the subject of interests in 
many scientific researches due to their positive effects on human health, attributed 
mainly to their antioxidant activities (Kojic et al., 2011).  
DPPH assay is a stable free radical method. It is an easy, rapid and sensitive 
way to survey the antioxidant activity of a specific compound or plant extract 
(Koleva, Beek, Linssen, Groot and Evstatieva, 2002). The principle of DPPH method 
is based on the reduction of DPPH in the presence of a hydrogen donating antioxidant 
due to the formatiom of diphenyl picryl hydrazine (Rajan, Gokila, Jency, Brindha and 
Sujatha, 2011). The results indicated that the aqueous extract of A. crassna decrease 
in the DPPH radical may be due to the scavenging ability of A. crassna. Free radical 
scavenging activity was increased with an increasing concentration.  
ABTS assay is base on the scavenging of light by ABTS radicals. ABTS 
radical cation has been often used in the evaluation of antioxidant activity of single 
compounds and complex mixtures of various origins (body fluids, foods, beverages, 
plant extracts) (Katalinic, Milos, Kulisic and Jukic, 2006). An antioxidant with an 
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ability to donate a hydrogen atom will quench the stable free radical, a process that is 
associated with a change in absorption. The relatively stable ABTS radical was green 
and it was quantified spectrophotometrically at 734 nm. The ABTS scavenging 
capacity of the extract was comparable with that of the standard BHT (Rajan, Gokila, 
Jency, Brindha and Sujatha, 2011). 
Ferric reducing antioxidant power (FRAP) assay was used to evaluate the 
antioxidant potential of A. crassna leaves extract. Principally, FRAP assay treats the 
antioxidants in the sample as reductant in a redox-linked colorimetric reaction (Guo et 
al., 2003). This assay is relatively simple and easy to conduct. FRAP assay measures 
the reducing potential of antioxidant to react on ferric tripyridyltriazine (Fe
3+
- TPTZ) 
complex and produce blue color of ferrous which can be detected at absorbance 593 
nm (Benzie and Strain, 1996). Antioxidant compound which acts as reducing agent 
exert their effect by donating hydrogen atom to ferric complex and thus breaking the 
radical chain reaction. The higher the absorbance is, the higher is the antioxidant 
activity which is indicated by the high FRAP value.  
As shown in appendix A1, maximum scavenging activity (91.52%) was 
observed at 50 µg/ml by DPPH method. The half inhibition concentration (IC50) of A. 
crassna leaves extract and ascorbic acid were found to be 7.25 µg/ml and 1.33 µg/ml 
respectively (Table 4.2). The scavenging activity of A. crassna leaves extract against 
ABTS radical is in a concentration dependent manner. The percentage inhibition of 
the extract (96.60%) was observed at 1,200 µg/ml concentration (Appendix A2). The 
IC50 values of the extract and BHT were 218.93 µg/ml and 83.09 µg/ml, respectively. 
The FRAP value, expressed in µmol of Fe
2+
/ mg dried extract, was found in A. 
crassna leaves extract at 1.175 µmol of Fe
2+
/ mg dried extract. These results indicated 
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that the aqueous extract of A. crassna leaves exhibited substantial antioxidant 
activity in all of the methods used. 
 In addition to antioxidant activity, plant phenolic compounds have been 
shown to possess antimicrobial activities (Ayoola et al., 2008; Omogbai and Eze, 
2010; Shan, Cai, Brooks and Corke, 2007), suggesting that the extract has the 
potential to possess antimicrobial activity. Recently, a group of researchers from 
Japan has reported   antibacterial activities of the aqueous extract of A. crassna leaves 
against enteric bacteria, such as S. aureus, Clostoridium difficile, Peptostreptococcus 
anaerobius and Bacteroides fragilis (Kakino et al., 2012). Herein, the inhibitory 
effect on the Gram-positive bacteria      S. epidermidis was observed by agar disc 
diffusion technique. This type of microorganism is one of coagulase-negative 
staphylococci which become increasingly recognized as pathogen of nosocomial 
infection, following ophthalmologic, neurologic and cardiothoracic surgery, in 
immunocompromised patients and in patients with prosthetic devices. This microbe 
was found susceptible to the extract with MIC of 6 mg/ml, which is in the range of 
MICs (4-8 mg/ml) against other bacterial strains reported by Kakino and 
colleagues (Kakino et al., 2012). It was further found that the extract exhibited 
bactericidal activity with MBC of 12 mg/ml.  
The ability to form biofilm, a slimy layer with embedded microcolonies, is 
one of the most important and one of the most widespread virulence factors occurring 
in microbes. Biofilms grows easily on surfaces of artificial materials used for 
catheters and prosthetic devices (Stewart and Costerton, 2001) and it is estimated that 
biofilms are associated with about 65% of nosocomial infections. It has been 
suggested that biofilm formation is the main virulence mechanism of S. epidermidis 
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(Vuong and Otto, 2002). In addition to growth inhibitory effect, the extract was found 
to impede the production of slimy biofilm by S. epidermidis similar to vancomycin 
which has been shown to inhibit S. epidermidis biofilm formation (Aybar et al., 
2012).   
Crystal violet staining of surface-attached cells by microtiter plate assay is a 
popular and convenient method for quantitative detection of bacterial biofilm 
formation, however direct microscopic observation is strongly recommended to 
confirm the data from staining analysis (Merritt, Kadouri and O’Toole, 2011). Due to 
the absorption of A. crassna leaf extract at 595 nm, therefore in the present study the 
effect on biofilm formation was investigated by microscopic analysis which gave 
more accurate information. The phase contrast microscopic images (Fig 4.5) showed 
that S. epidermidis formed vast empty regions on surface with a few clusters of cells 
and scattering of single cell at the MICs of A. crassna extract. Vancomycin which has 
been shown to inhibit the production of slimy biofilm by S. epidermidis (Aybar et al., 
2012) was used as positive control. 
It is widely accepted that plants are good sources of novel antimicrobial 
agents. Screening of antimicrobial activities to find which type of bacteria is 
susceptible to plant extracts is useful, however the investigation of underlying 
mechanism is also crucial for drug development. To explore the possible antibacterial 
mechanism, the effect of the extract on morphological changes of S. epidermidis cells 
was studied by SEM and TEM. Vancomycin, an antibiotic which is widely known to 
damage bacterial cell wall of most Gram-positive bacteria, including staphylococci 
and enterococci, was used as positive control. As revealed by SEM, bacterial cells 
treated with aqueous extract of A. crassna leaves appeared swollen and distorted after 
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24 h of incubation. Moreover, as evident by TEM monographs, the extract caused 
rupture of bacterial cell wall and alteration of bacterial shape compared to control. It 
has been reported that biofilm formation process consists of two steps, of which the 
staphylococci first adhere to the foreign-body surface and then accumulate into a 
complex biofilm structure (Mack et al., 2006). The interaction between specific 
adhesions located on cell wall and extracellular matrix components deposit on the 
surface is essential for the primary attachment. The destruction of cell wall by the 
extract is likely to cause bacteria unable to grow and create primary biofilm 
architecture.  
The disadvantage of this study is the lack of identification of the active 
ingredients which are responsible for the antibacterial effects. However, there are 
some documents explaining possibility action of phenolic compounds. The 
mechanisms of action of each phenolic againt various bacteria were quite complicated 
(Kalemba and Kunicka, 2003). However there are some documents that explain 
possibility mechanisms of action for their antimicrobial activities, such as degradation 
of cell wall, interaction with cellular composition and disrupt the cytoplasmic 
membrane of bacteria (Shan, Cai, Brooks and Corke, 2007). Several mechanisms of 
antimicrobial activity of tannins have been proposed including inhibition of 
extracellular microbial enzymes and metabolisms, deprivation of the substrates 
required for microbial growth and destabilization of cytoplasmic and plasma 
membranes (Pimia, Nohynek, Alakomi, Marja and Caldentey, 2005; Min et al., 
2008). In addition, tannin compounds to cause the bacterial cells to disintegrate 
possibly results from their interference with the bacterial cell wall thereby inhibiting 
the microbial growth (Erasto, Moleta and Majinda, 2004; Viljoen et al., 2003). The 
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data obtained in this study provide additional indirect evidence that phenolic 
compounds may contribute the antibacterial effect of plant extract by damaging 
bacterial cell wall. The active ingredients responsible for this action need further 
investigation. 
A number of chemicals or plant extracts have shown strong in 
vitro antimicrobial activities with low MIC, however not all of them can be used in 
vivo due to their high toxicity. Because the extract showed relatively high MICs, the 
acute toxicity of aqueous  A. crassna leaf extract was investigated to assess its in 
vivo safety and the results showed that all mice did not exhibit abnormal signs of 
toxicity or deaths after receiving the extract even at high dose (15,000 mg/kg body 
weight). 
It is claimed in the commercial advertisements of A. crassna herbal tea that it 
possesses an antidiabetic activity. One of the experiments in the present study was 
aimed to examined whether the aqueous extract produced hypoglycemic activity in 
vivo. STZ is selective pancreatic islet beta cell cytotoxicity. STZ is taken up by the β 
cells via the glucose transporter GLUT-2 and causes alkylation of DNA (Prasad, 
Kulshreshtha and Qureshi, 2009). Sulfonylureas are commonly used as a standard 
antidiabetic drug in STZ induced diabetes to compare the efficacy of variety of 
hypoglycemic drugs (Fernandes, Lagishetty, Panda and Naik, 2007; Arulmozhi, 
Mazumder, Lohidasan and Thakurdesai, 2010 ). In this study, glibenclamide in 
sulfonylurea group is used as a standard drug to compare the antidiabetic activity of 
A. crassna. The main mechanism of action of glibenclamide is the stimulation of 
insulin release and the inhibition of glucagon secretion (Suba et al., 2004). The islets 
of Langerhans of the glibenclamide treated group was resumed to be normal structure 
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similar to those in the study by Prasad and co-workers (Prasad, Kulshreshtha and 
Qureshi, 2009). The results showed that blood glucose level did not decrease after 15 
days of treatment when compared to glibenclamide-treated group. Decreased body 
weight were observed in both diabetic control and A. crassna treated group, thus 
indicating the extract lacked antidiabetic activity resulting in excessive breakdown of 
tissue proteins of experiment animals. Although, the extract consists of antioxidant 
activity, it did not show any protective effect against cytotoxicity of STZ on pancreas 
as seen in Figure 4.7. It is possible that the antioxidant compounds may not reach 
pancreatic cells which are the target organ. 
 
Conclusion 
This research was designed to investigate the preliminary phytochemical 
property, toxicity, antioxidant, antibacterial and antidiabetic activities of the aqueous 
A. crassna leaf extract. The results showed that flavonoids, saponins, tannins, cardiac 
glycosides were present. Total phenolic compound of the plant extract was 176.61 mg 
GAE/g using Folin-Ciocalteau assay. The results showed that the aqueous extract 
of A. crassna leaves exhibited quite strong antioxidant activities in all methods tested 
including DPPH, ABTS, FRAP assays. More importantly, the antibacterial activity 
and inhibitory effect on biofilm formation of the extract against S. epidermidis were 
demonstrated. The postulated underlying mechanism was disruption of bacterial cell 
wall. In addition, high dose of the extract showed the absence of acute oral toxicity in 
mice. The data also suggest that A. crassna may be a potential source for the 
discovery of new antibacterial agents against S. epidermidis and probably other 
Gram-positive bacteria as well. 
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In term of antidiabetic activity, the data obtained from this study suggested 
that the extract did not possess antihyperglycemic effect in vivo (STZ induce diabetic 
rats type I). 
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